Close

Pfizer looks beyond COVID after quarterly loss on Paxlovid charge Oct 31, 2023 06:49AM
Pfizer (PFE) stock can outperform even in a 'trough COVID' scenario says Goldman Sachs Jan 10, 2023 01:43PM
Mirati Therapeutics (MRTX) seen worth more than double in a buyout Nov 23, 2022 12:40PM
Pfizer boosts COVID vaccine sales forecast by $2 billion Nov 1, 2022 06:50AM
BMO Capital Reiterates Outperform Rating on Pfizer (PFE) as Early-Stage Oral GLP-1s Show Promise in T2D & Obesity Sep 22, 2022 07:35AM
View Older Stories

Apr 7, 2022 08:18AM BMO Capital Reiterates Outperform Rating on Pfizer (PFE) but Does Not See ReViral Acquisition "Impactful for Pfizer's Nearer-Term P&L"
Apr 7, 2022 06:58AM Pfizer boosts respiratory drug portfolio with ReViral purchase
Mar 23, 2022 07:54AM BMO Capital Reiterates Pfizer (PFE) at Ourperform, $76 PT, Sees etrasimod Better Positioned vs BMY's Zeposia
Mar 1, 2022 08:25AM BMO Capital Reiterates Pfizer (PFE) at Outperform, CLOVER Trial is Not Core but Substantial Attenuation in Infection is Encouraging Despite Endpoint Miss
Feb 8, 2022 07:47AM Pfizer (PFE) Reiterated at Outperform by BMO Capital Following Earnings Report
Jan 14, 2022 05:41AM Pfizer (PFE) PT Raised to $76 at BMO Capital, Reiterated as Top Pick, COVID 2022 Revenue Estimates Hiked to $63B from $40B
Dec 13, 2021 09:30AM Pfizer’s (PFE) $6.7B Arena Acquisition is Priced Reasonably, May Offer Additional Upside, Pfizer Making Good Use of Cash – Analyst
Dec 13, 2021 06:41AM Pfizer (PFE) to Buy Arena Pharmaceuticals (ARNA) in a $6.7 Billion Deal, Pays a 100% Premium; Seen as the First of Many Acquisitions
Nov 30, 2021 07:11AM COVID-19 Omicron Variant: Analysts Discuss Which Biopharma Stock is Best Positioned
Nov 18, 2021 04:19PM UPDATE: BMO Capital Starts Pfizer (PFE) at Outperform
Nov 17, 2020 07:33PM U.S. dollar weakens for fifth day on vaccine optimism
Nov 11, 2020 07:12AM Sonoco Products (SON) PT Raised to $65 at BMO Capital Following News of Effective COVID Vaccine
Jul 20, 2020 09:33AM Pre-Open Movers 07/20: (SRNE) (BNTX) (NBL) Higher; (NKLA) (MRNA) Lower (more...)
May 8, 2019 09:04AM Pfizer (PFE) PT Lowered to $44 at BMO Capital
Jan 31, 2019 12:21PM Pfizer (PFE) Risk/Reward Seems Favorable, But Not Enough for Upgrade - BMO
Dec 13, 2018 07:34AM BMO Capital Reiterates Market Perform on Pfizer (PFE) Following Investor Meetings
Nov 1, 2018 04:17AM BMO Capital Downgrades Pfizer (PFE) to Market Perform
Sep 10, 2018 08:25AM Expert Call Increases Confidence In The Acceleration Of Pfizer's (PFE) ATTRCM Diagnosis Rate - BMO
Sep 6, 2018 08:27AM Pfizer (PFE) PT Raised to $47 at BMO Capital; Sees Tafamidis as a $3.5B+ Drug
Jun 1, 2018 01:21PM Olumiant 2mg FDA Approval is Incrementally Negative for AbbVie (ABBV) - BMO
Apr 19, 2018 09:41AM Bari Adcom Negative for Eli Lilly (LLY) and AbbVie (ABBV), Positive for Pfizer (PFE) - BMO
Jan 31, 2018 05:01AM Pfizer (PFE) PT Raised to $43 at BMO Capital
Jan 30, 2018 03:01PM AbbVie (ABBV), Eli Lilly (LLY) More Vulnerable Than Other Drug Cos. on Amazon Entry - BMO
Jan 30, 2018 12:54PM Pfizer (PFE) Not Hungry for a Large Deal - BMO
Nov 13, 2017 06:51AM Pfizer (PFE) Should Buy Biogen (BIIB) Instead - BMO
Oct 19, 2017 05:59AM Pfizer (PFE) PT Raised to $39 at BMO Capital
Oct 10, 2017 10:23AM Pfizer (PFE) Consumer Health Unit Sale Would Be 'Incrementally Positive' - BMO
Aug 2, 2017 06:11AM BMO Capital Upgrades Pfizer (PFE) to Outperform
Jul 13, 2017 08:52AM If AstraZeneca (AZN) Soriot Rumors are True, It Becomes a Pfizer (PFE) Acquisition Target Again; Negative for Bristol-Myers (BMY)
Jan 31, 2017 03:04PM Bristol-Myers Squibb (BMY) Takeover Less Likely Following Pfizer (PFE) Call - BMO
Jan 30, 2017 06:50AM Pfizer (PFE): 4Q Should Be OK But Guidance Could Be Light - BMO
Nov 9, 2016 12:03PM Complete Donald Trump Stock Impact Guide
Nov 9, 2016 07:54AM Major Pharma Got a Major Win Last Night - BMO
Nov 2, 2016 07:07AM BMO Capital Downgrades Pfizer (PFE) to Market Perform
Nov 2, 2016 06:20AM BMO Capital Downgrades Pfizer (PFE) to Market Perform
Oct 18, 2016 07:08AM Inflectra's U.S. Launch Incrementally Positive for Pfizer (PFE), Negative for AbbVie (ABBV) - BMO
Sep 30, 2016 12:08PM Streetinsider.com's Hot Lunchtime Reads 9/30: (PEP) (OZM) (QCOM) (TSLA)
Aug 22, 2016 12:09PM BMO 'Neutral to Positive' on Pfizer's (PFE) Medivation Takeover
Aug 22, 2016 09:41AM Vertex (VRTX), BioMarin (BMRN), Intercept (ICPT), Others Highlighted as Targets at BMO Following PFE/MDVN
Aug 2, 2016 08:07AM Pfizer beats estimates, but branded drugs disappoint
May 12, 2016 10:38AM Notable Analyst Rating Changes 5/12: (AUY) (SNY) (WBMD) Upgraded; (ENSG) (M) (PMTS) Downgraded
May 4, 2016 06:59AM Pfizer (PFE) Target Increases at BMO Capital Following a Good Quarter
Apr 6, 2016 10:42AM BMO Capital Reiterates Outperform on Pfizer (PFE) Following Allergan Merger Termination
Apr 5, 2016 06:02PM After-Hours Stock Movers 04/05: (PLCM) (PFE) (AMGN) Higher; (CREE) (LINE) (WYNN) Lower (more...)
Apr 5, 2016 06:53AM New Treasury Action Could Block, or Significantly Change Pfizer (PFE)/Allergan (AGN) Deal - BMO Capital
Feb 3, 2016 08:21AM BMO Capital Reiterates Outperform on Pfizer (PFE) Following 4Q
Jan 12, 2016 10:50AM EU Decision on Belgium Taxes Negative for the Group - BMO Capital (ZTS) (VRX) (LLY) (PFE)
Oct 29, 2015 09:50AM Potential Allergan (AGN), Pfizer (PFE) Tie-Up No Surprise But May Take $400 to Get Done
Sep 25, 2015 07:05AM BMO Capital Remains Bullish on Pfizer (PFE) as Split Becomes More Likely
Jul 29, 2015 07:30AM Pfizer (PFE) PT Lifted to $41 at BMO Capital on Sum-of-the-Parts
View Older Stories